Related Experiment Video
Updated: Dec 27, 2025

14:40
Exploring m6A and m5C Epitranscriptomes upon Viral Infection: an Example with HIV
Published on: March 5, 2022
3.7K
Selectively Disrupting m6A-Dependent Protein-RNA Interactions with Fragments
Rajiv Kumar Bedi1, Danzhi Huang1, Lars Wiedmer1
1Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
ACS Chemical Biology
|February 27, 2020
Summary
Researchers analyzed small-molecule ligands for the human YTHDC1 protein, which binds N6-methylated adenine (m6A) in RNA. The study identified 30 fragments that mimic key m6A interactions, aiding in the design of YTHDC1 modulators.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- N6-methylated adenine (m6A) is a crucial RNA modification.
- YTHDC1 is a key protein domain that recognizes m6A modifications in RNA.
- Understanding YTHDC1-m6A interactions is vital for RNA biology and disease research.
Purpose of the Study:
- To perform a crystallographic analysis of small-molecule ligands binding to the human YTHDC1 domain.
- To identify and characterize fragments that mimic the binding interactions of m6A.
- To provide structural insights for designing modulators of YTHDC1 activity.
Main Methods:
- Crystallographic analysis of YTHDC1-ligand complexes.
- Virtual screening to identify potential small-molecule binders.
- Structure-based analysis of ligand-protein interactions.
Main Results:
- 30 small-molecule fragments (< 300 g mol-1) representing 10 chemotypes were identified as YTHDC1 binders.
- Most fragments successfully emulate key interactions of the m6A N6-methyl group, including hydrogen bonding to Ser378 and van der Waals contacts with the tryptophan cage.
- Some identified fragments exhibit favorable ligand efficiency and selectivity for YTHDC1 over other m6A reader domains.
Conclusions:
- The identified fragments provide valuable structural information for understanding YTHDC1-m6A recognition.
- These findings can guide the rational design of novel therapeutic agents targeting YTHDC1-mediated pathways.
- The study highlights the potential of fragment-based drug design for modulating RNA epigenetic marks.
Related Concept Videos
RNA Interference
27.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs
3.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
siRNA - Small Interfering RNAs
18.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K
Types of RNA
8.6K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
8.6K

